TTBKS AS MODIFIERS OF THE BETA CATENIN PATHWAY AND METHODS OF USE

摘要

Human TTBK genes are identified as modulators of the beta catenin pathway, and thus are therapeutic targets for disorders associated with defective beta catenin function. Methods for identifying modulators of beta catenin, comprising screening for agents that modulate the activity of TTBK are provided.